| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $23.2M | +422.5% |
| Cost of Revenue | $4.7M | -92.2% |
| Gross Profit | $89.3M | +260.6% |
| R&D Expense | $16.3M | -22.3% |
| SG&A Expense | $36.3M | -28.3% |
| Operating Income | $29.6M | +121.9% |
| Pre-tax Income | $32.6M | +125.1% |
| Income Tax | $6K | +500.0% |
| Net Income | $32.5M | +125.1% |
| EPS (Basic) | $5.36 | +124.1% |
| EPS (Diluted) | $5.22 | +123.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.9M | -41.1% |
| Accounts Receivable | $764K | -83.7% |
| Inventory | $0 | -100.0% |
| Current Assets | $39.1M | -53.2% |
| Total Assets | $44.3M | -58.6% |
| Current Liabilities | $12.6M | -87.6% |
| Total Liabilities | $15.3M | -86.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.8M | +45.8% |
| Capital Expenditures | $264K | -79.0% |
| Investing Cash Flow | $13.1M | -84.8% |
| Financing Cash Flow | -$59K | -104.4% |
| Free Cash Flow | -$39.1M | +46.3% |
| Stockholders' Equity |
| $29.0M |
| +462.0% |